30 Stocks Moving In Tuesday's Mid-Day Session



  • TSR, Inc. TSRI shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $23.9 million, versus $16.1 million year over year.
  • Accolade, Inc. ACCD gained 27.3% to $24.36 after the company reported Q3 earnings results and raised FY22 sales guidance.
  • Nuverra Environmental Solutions, Inc. NES shares jumped 22.6% to $2.8450.
  • BARK, Inc. BARK gained 18% to $4.25. The company said it expects Q3 sales of $140 million, versus analysts’ estimates of $137.3 million. BARK co-founder and executive chairman Matt Meeker will cecome CEO.
  • Nutriband Inc. NTRB jumped 17.2% to $7.08. Nutriband and Kindeva Drug Delivery, on Monday, signed a feasibility agreement to develop AVERSA Fentanyl, an abuse deterrent fentanyl patch.
  • Veru Inc. VERU surged 17% to $6.25. Veru, on Monday, said that its Enobosarm was granted fast track designation by the FDA.
  • Cingulate Inc. CING jumped 15% to $2.82. Aegis Capital initiated coverage on Cingulate with a Buy rating and announced a price target of $9.
  • Shake Shack Inc. SHAK gained 13.3% to $77.35 after the company issued Q4 and FY21 sales guidance above guidance.
  • Molecular Partners AG MOLN rose 12.6% to $24.22. Molecular Partners shares jumped over 30% on Monday after the company, and Novartis, reported topline data from the Phase 2 study for ensovibep, a DARPin antiviral therapeutic for COVID-19.
  • Cognition Therapeutics, Inc. CGTX gained 12.4% to $6.74. The company, on Monday, issued summary of its 2021 accomplishments and outlined upcoming milestones anticipated in the year ahead.
  • CVD Equipment Corporation CVV jumped 11.8% to $4.54. CVD Equipment said orders exceeded $5 million in Q4 and $21 million overall for FY21.
  • Quantum Computing, Inc. QUBT gained 11.6% to $3.26.
  • Micro Focus International plc MFGP climbed 11.6% to $6.30.
  • Future FinTech Group Inc. FTFT rose 11.5% to $1.16 after dropping 10% on Monday. Future FinTech recently named Ola Lind as Chief Strategy Officer.
  • Micro Focus International plc MFGP rose 11.3% to $6.28.
  • Sonendo, Inc. SONX rose 11.2% to $6.27 after the company issued strong sales forecast for the fourth quarter.
  • Tivic Health Systems, Inc. TIVC surged 10.6% to $3.13.
  • OneSmart International Education Group Limited ONE gained 9.1% to $0.2120. OneSmart International Education Group received notification from NYSE regarding delayed Form 20-F filing.
  • Cellectis S.A. CLLS gained 7.5% to $8.51. Cellectis' licensed partner, Allogene Therapeutics, announced removal of FDA clinical hold on their clinical trials.
  • Illumina, Inc. ILMN climbed 7.5% to $389.34 as the company issued strong sales forecast for 2022, and also reported four partnership agreements.
  • Inari Medical, Inc. NARI rose 5.3% to $89.25 after the company issued strong Q4 and FY21 sales guidance.
  • Abercrombie & Fitch Co. ANF rose 5.3% to $34.06 as the company issued an update on its forecast for the 2021 fiscal year. The company said it sees preliminary FY21 net sales rising 19% to 20% from 2020. The company also projects Q4 net sales up in the range of 4% to 6% from 2020.

Check out these big penny stock gainers and losers


  • Huadi International Group Co., Ltd. HUDI shares fell 57.4% to $11.67.
  • Capstar Special Purpose Acquisition Corp. CPSR shares dipped 25.7% to $7.35.
  • Bone Biologics Corporation BBLG fell 21.9% to $4.21. Bone Biologics shares surged 57% on Monday following the company's presentation at the HC Wainwright BioConnect Virtual Conference.
  • Pacific Biosciences of California, Inc. PACB fell 12.6% to $14.49 after the company issued Q4 and FY21 sales guidance below estimates. The company announced preliminary revenue of approximately $36 million for its fourth quarter, below the consensus estimate of $36.58 million.
  • Albertsons Companies, Inc. ACI dropped 10.8% to $28.45. Albertsons Companies reported upbeat earnings for its third quarter and boosted its FY21 forecast.
  • Esports Technologies, Inc. EBET fell 8.7% to $14.63.
  • Creative Medical Technology Holdings, Inc. CELZ shares declined 8.7% to $3.05.
  • Reviva Pharmaceuticals Holdings, Inc. RVPH fell 8.4% to $2.72. The FDA, on Monday, notified Reviva Pharmaceuticals that it may proceed with Phase 3 trial of its lead candidate, brilaroxazine, a serotonin and dopamine receptor modulator for schizophrenia.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!